The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 10, 2017

Filed:

Dec. 19, 2014
Applicants:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Lycera Corporation, Ann Arbor, MI (US);

Inventors:

Thomas D. Aicher, Ann Arbor, MI (US);

Chad A. VanHuis, Hartland, MI (US);

John MacLean, Brookline, MA (US);

Brian M. Andresen, Boston, MA (US);

Kenneth J. Barr, Boston, MA (US);

Corey Bienstock, Natick, MA (US);

Matthew Daniels, Somerville, MA (US);

Kun Liu, Boston, MA (US);

Yuan Liu, Billerica, MA (US);

Catherine White, Boston, MA (US);

Nunzio Sciammetta, Boston, MA (US);

Vladimir Simov, Boston, MA (US);

Assignees:

Lycera Corporation, Ann Arbor, MI (US);

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 265/36 (2006.01); A61K 31/538 (2006.01); C07D 413/12 (2006.01); C07D 513/04 (2006.01); C07D 417/12 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01);
U.S. Cl.
CPC ...
C07D 265/36 (2013.01); A61K 31/538 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 513/04 (2013.01);
Abstract

The invention provides certain benzoxazine compounds of the Formula (I) or pharmaceutically acceptable salts thereof wherein R, R, R, R, R, R, R, R, and Cy are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds of the Formula (I) or pharmaceutically acceptable salts thereof, and methods of using the compounds of the Formula (I) or pharmaceutically acceptable salts thereof or pharmaceutical compositions comprising the same for treating diseases or conditions mediated by RORgammaT.


Find Patent Forward Citations

Loading…